Research Overview of HPA Axis in Depression
-
摘要: 抑郁症临床上的主要特点为显著而持久的心境低落,其高发病率和高致残性给个人、家庭及社会都带来了沉重的负担。近年来针对抑郁患者神经内分泌方面的研究表明,以下丘脑-垂体-肾上腺皮质轴(The hypothalamic–pituitary–adrenal axis,HPA axis)紊乱为主的失调在抑郁症的发病过程中起到了重要作用。综述近年来HPA轴与抑郁症的研究进展,以期为抑郁症的诊断与治疗提供新的思路及参考价值。
-
关键词:
- 抑郁症 /
- 下丘脑-垂体-肾上腺轴 /
- 促肾上腺皮质激素释放激素 /
- 促肾上腺皮质激素 /
- 皮质醇
Abstract: The main clinical feature of depression is marked and persistent low mood, and its high incidence and high disability have brought a heavy burden to individuals, families and society. Recent studies on neuroendocrine in patients with depression have shown that disorders of the hypothalamic-pituitary-adrenocortical axis (HPA axis) plays an important role in the pathogenesis of depression. This article reviews the research progress of HPA axis and depression in recent years, in order to provide new ideas and reference value for the diagnosis and treatment of depression. -
[1] Gin,Malhi,John,et al. Depression[J]. Lancet,2018,392(10161):2299-2312. doi: 10.1016/S0140-6736(18)31948-2 [2] Theo Vos Amanuel Alemu Abajobir,Cristiana Abbafati,et al. Global,regional,and national incidence,prevalence,and years lived with disability for 328 diseases and injuries for 195 countries,1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet,2017,390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2 [3] Tang A L,Thomas S J,Larkin T. Cortisol,oxytocin,and quality of life in major depressive disorder[J]. Quality of Life Research,2019,28(11):2919-2928. doi: 10.1007/s11136-019-02236-3 [4] Sher,Leo. The role of the hypothalamic-pituitary-adrenal axis dysfunction in the pathophysiology of alcohol misuse and suicidal behavior in adolescents[J]. International journal of adolescent medicine and health,2007,19(1):3-9. doi: 10.1515/IJAMH.2007.19.1.3 [5] 苏文君,职晓松,张懿,et al. 抑郁症与代谢综合征的神经内分泌免疫联系[J]. 现代生物医学进展,2017,17(11):4. doi: 10.13241/j.cnki.pmb.2017.11.050 [6] Lok A,Mocking R J T,Ruhé H G,et al. Longitudinal hypothalamic–pituitary–adrenal axis trait and state effects in recurrent depression[J]. Psychoneuroendocrinology,2012,37(7):892-902. doi: 10.1016/j.psyneuen.2011.10.005 [7] Keenan K,Hipwell A,Babinski D,et al. Examining the developmental interface of cortisol and depression symptoms in young adolescent girls[J]. Psychoneuroendocrinology,2013,38(10):2291-2299. doi: 10.1016/j.psyneuen.2013.04.017 [8] 李文娜,谈博,孙一珂,et al. 抑郁症患者褪黑素与HPA轴的四季变化规律[J]. 中华中医药杂志,2022,37(5):5. [9] Burbridge S,Stewart I,Placzek M. Development of the Neuroendocrine Hypothalamus[J]. Comprehensive Physiology,2015,6(2):623-643. [10] Joseph J J,Golden S H. Cortisol dysregulation: the bidirectional link between stress,depression,and type 2 diabetes mellitus[J]. Ann N Y Acad,2017,1391:20-34. doi: 10.1111/nyas.13217 [11] 李云峰,罗质璞. 应激诱发抑郁症机制的研究进展[J]. 生理科学进展,2002,33(2):3. [12] Guerry J D,Hastings P D. In Search of HPA Axis Dysregulation in Child and Adolescent Depression[J]. Clinical Child & Family Psychology Review,2011,14(2):135-160. [13] Braquehais M D,Picouto M D,Casas M,et al. Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide[J]. World Journal of Pediatrics,2012,8(3):197-206. doi: 10.1007/s12519-012-0358-0 [14] Johns E C,Denison F C,Reynolds R M. The impact of maternal obesity in pregnancy on placental glucocorticoid and macronutrient transport and metabolism[J]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,2019,1866(2):165374. [15] Mcaloon J, Fassaie S, Fassaie S, et al. Maternal distress, HPA activity, and antenatal interventions: A systematic review. Psychoneuroendocrinology, 104477 [J]. 2019. [16] Sandman,Curt A. Fetal exposure to placental corticotropin-releasing hormone (pCRH) programs developmental trajectories[J]. Peptides,2015,72:145-153. doi: 10.1016/j.peptides.2015.03.020 [17] Rose G,Crocco P,Rango F D,et al. MECHANISMS OF AGEING AND DEVELOPMENT[J]. Mechanisms of Ageing & Development,2015,150(12):24-32. [18] Dickens M J,Pawluski J L. The HPA Axis During the Perinatal Period: Implications for Perinatal Depression[J]. Endocrinology,2018(11):11. [19] Gaffey A E,Bergeman C S,Clark L A,et al. Aging and the HPA axis: Stress and resilience in older adults[J]. Neuroscience & Biobehavioral Reviews,2016:928-945. [20] Deepashree,Gupta,John,et al. Hypothalamic-Pituitary-Adrenal (HPA) Axis and Aging[J]. Comprehensive Physiology,2014,4(4):1495-1510. [21] Ruhé H G,Khoenkhoen S J,Ottenhof K W,et al. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder[J]. Psychoneuroendocrinology,2014,52(1):261-271. [22] Kasckow J W,Baker D,Geracioti T D. Corticotropin-releasing hormone in depression and post-traumatic stress disorder[J]. Peptides,2001,22(5):850-851. [23] Watson S,Gallagher P,Ritchie J C,et al. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder[J]. Br J Psychiatry,2004,184(6):496-502. doi: 10.1192/bjp.184.6.496 [24] 顾正天,严婷婷,何明利. 重复经颅磁刺激对抑郁症患者的抑郁程度和HPA轴的影响[J]. 青岛医药卫生,2009,41(3):161-163. doi: 10.3969/j.issn.1006-5571.2009.03.001 [25] Morris M C,Rao U,Garber J. Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators[J]. Journal of Affective Disorders,2012,143(1-3):223-230. doi: 10.1016/j.jad.2012.05.059 [26] Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective[J]. Int J Environ Res Public Health,2018,15(7):1425. doi: 10.3390/ijerph15071425 [27] Beurel E,Toups M,Nemeroff C B. The Bidirectional Relationship of Depression and Inflammation: Double Trouble[J]. Neuron,2020,107(2):234-256. doi: 10.1016/j.neuron.2020.06.002 [28] 王振华,陈海支,费小聪,et al. 抑郁症患者自杀意念与神经内分泌相关性研究[J]. 中国现代医药杂志,2017,19(11):21-25. doi: 10.3969/j.issn.1672-9463.2017.11.006 [29] 丁毅,杨玉玲,陈华敏,et al. 抑郁症患者自杀风险的外周生物学预测指标[J]. 国际精神病学杂志,2018,45(2):4. doi: 10.13479/j.cnki.jip.2018.02.009 [30] Waters R P,Rivalan M,Bangasser D A,et al. Evidence for the role of corticotropin-releasing factor in major depressive disorder[J]. Neuroscience & Biobehavioral Reviews,2015,60:63-78. [31] Stetler C,Miller G E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research[J]. Psychosomatic Medicine,2011,73(2):114. doi: 10.1097/PSY.0b013e31820ad12b [32] Rohleder N,Wolf J M,Wolf O T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder[J]. Neuroscience & Biobehavioral Reviews,2011,35(1):104-114. [33] Kloet E R D,Derijk R H,Meijer O C. Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?[J]. Nature Reviews Endocrinology,2007,3(2):168. doi: 10.1038/ncpendmet0403 [34] 王晓乐,王东林. 下丘脑异常与抑郁症[J]. 心理科学进展,2015,23(10):1763-1774. [35] CHLOE P,O'connell,et al. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein[J]. The American Journal of Psychiatry,2018,175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172 [36] Neumann,Wigger,Torner,et al. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus[J]. Journal of Neuroendocrinology,2010,12(3):235-243. [37] 高之涵,金卫东. 抗抑郁药物与抑郁症HPA轴功能关系的研究进展[J]. 医药导报,2017,36(6):659-664. [38] Harmer C J,Duman R S,Cowen P J. How do antidepressants work? New perspectives for refining future treatment approaches[J]. The Lancet Psychiatry,2017,4(5):409-418. doi: 10.1016/S2215-0366(17)30015-9 [39] Bschor T,Ising M,Erbe S,et al. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients[J]. Journal of Psychiatric Research,2012,46(1):111-117. doi: 10.1016/j.jpsychires.2011.09.020 [40] Künzel H,Binder E B,Nickel T,et al. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients,measured by the Dex-CRH test[J]. Neuropsychopharmacology Official Publication of the American College of Neuropsychopharmacology,2003,28(12):2169-2178. doi: 10.1038/sj.npp.1300280 [41] Fischer S,Macare C,Cleare A J. Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response–Meta-analysis[J]. Neuroscience & Biobehavioral Reviews,2017,83:200-211. [42] 彭允中. 米非司酮药理作用和临床研究新进展[J]. 医药导报,2013,32(1):3. doi: 10.3870/yydb.2013.01.021 [43] Mk A,Hds A,Jm A,et al. Efficacy and safety of TS-121,a novel vasopressin V1B receptor antagonist,as adjunctive treatment for patients with major depressive disorder: A randomized,double-blind,placebo-controlled study - ScienceDirect[J]. Journal of Psychiatric Research,2020,128:43-51. doi: 10.1016/j.jpsychires.2020.05.017 [44] 王家艳,林晓伟,许玉皎. 滋水清肝饮加减联合氟哌噻吨美利曲辛对肾虚肝郁证老年脑梗死抑郁症患者的疗效及炎症因子和HPA轴的影响[J]. 中国老年学杂志,2020,40(15):4. [45] 王玉露,王月月,贾铷,et al. 天王补心丸对慢性不可预知应激抑郁模型小鼠行为学,HPA轴,海马GSK3β磷酸化及BDNF表达的影响[J]. 中国实验方剂学杂志,2020,26(21):7. doi: 10.13422/j.cnki.syfjx.20201864 [46] Holsboer F. Stress,hypercortisolism and corticosteroid receptors in depression:implicatons for therapy[J]. Journal of Affective Disorders,2001,62(1-2):77-91. [47] Liu Q S,Deng R,Fan Y,et al. Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates[J]. Molecular Nutrition & Food Research,2017,61(8):1-43. [48] Andreas,Menke. Is the HPA Axis as Target for Depression Outdated,or Is There a New Hope?[J]. Frontiers in psychiatry,2019,60:51-60. [49] O’connell C P,Goldstein-piekarski A N,Nemeroff C B,et al. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein[J]. American Journal of Psychiatry,2018,175(3):251-261. [50] Mocking R J T,Pellikaan C M,Lok A,et al. DHEAS and cortisol/DHEAS-ratio in recurrent depression: State,or trait predicting 10-year recurrence?[J]. Psychoneuroendocrinology,2015,59:91-101. doi: 10.1016/j.psyneuen.2015.05.006 [51] 朱笑彤,任园春,丰雷,et al. 运动干预在抑郁症治疗中的应用(综述)[J]. 中国心理卫生杂志,2021,35(1):26-31. doi: 10.3969/j.issn.1000-6729.2021.01.005
点击查看大图
计量
- 文章访问数: 3993
- HTML全文浏览量: 3951
- PDF下载量: 179
- 被引次数: 0